Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Lin  [Clear All Filters]
2023
Li L, Liu J, Wang W, Fu Y, Deng Y, Li X, Liu Z, Pang Y, Xu Y, Yan M, et al. Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment. Transl Oncol. 2023;35:101733.
Li L, Jiang H, Li Y, Xiang X, Chu Y, Tang J, Liu K, Huo D, Zhang X. Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of hippo pathway. Aging (Albany NY). 2023;15.
Li L, Ni R, Zheng D, Chen L. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells. Daru. 2023.
Tao H, Li L, Dong L, Chen H, Shan X, Zhuge L, Lou H. Growth differentiation factor 7 pretreatment enhances the therapeutic capacity of bone marrow-derived mesenchymal stromal cells against cerebral ischemia-reperfusion injury. Chem Biol Interact. 2023:110779.
Zou W, Lv Y, Zhang S, Li L, Sun L, Jiao J. Lysosomal dynamics regulate mammalian cortical neurogenesis. Dev Cell. 2023.
Jin H-Q, Jiang W-F, Zheng X-T, Li L, Fang Y, Yang Y, Hu X-W, Chu L-S. MiR-199a-5p enhances neuronal differentiation of neural stem cells and promotes neurogenesis by targeting Cav-1 after cerebral ischemia. CNS Neurosci Ther. 2023.
Pan X-W, Chen W-J, Xu D, Bin Guan W-, Li L, Chen J-X, Chen W-J, Dong K-Q, Ye J-Q, Gan S-S, et al. Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories. iScience. 2023;26(12):108370.
Fu Y, Dong W, Xu YT, Li L, Yu X, Pang Y, Chan L, Deng Y, Qian C. Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell-derived spheres. Naunyn Schmiedebergs Arch Pharmacol. 2023.
Li L, Xu L, Wang L-H. Triglyceride-Glucose Index as a Novel Biomarker of Prognosis in Patients With Acute Coronary Syndrome. Angiology. 2023:33197231182551.

Pages